Test description
Testing of genes associated with inherited sarcoma predisposition syndromes in patients with sarcoma or suggestive personal or family history.
Test information
BRAoVO Sarcoma Gene panel
Testing for patients with sarcoma, particularly those with early‑onset disease, multiple primary tumours, or a family history suggestive of an inherited cancer predisposition syndrome. Results may inform diagnosis, management, surveillance, and familial risk assessment.
BRCA1, BRCA2, CDKN2A, DICER1, MLH1, MSH2, MSH6, NBN, NF1, PMS2, POT1, RB1, SMARCA4, SMARCB1, TP53, WRN
Massively parallel sequencing
4 - 5 weeks
None.
$499.
Cancer genetics test request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.